Sign in to follow
Search Results

0 results for 'Sanofi SA'

You can use to get even better search results
April 25, 2013 |

Big Suits

N.J. Carpenters Health Fund v. NovaStar Mortgage; Apotex v. Bristol-Myers Squibb; Ryan et al. v. JPMorgan Chase
7 minute read
June 21, 2004 |

Buyers Find Hope in Vitamin Case

The justices declared that foreign plaintiffs cannot sue in U.S. courts for antitrust violations outside the United States-but left open one line of argument that could make potential plaintiffs happy.
2 minute read
December 04, 2006 |

FDA Appointee, Senator Clash Over Disclosure on Antibiotic

President Bush's choice to head the FDA is refusing to give Congress all the information it seeks about the controversial antibiotic Ketek, setting up further confrontations with Sen. Charles Grassley, R-Ia., who is blocking his nomination. The acting FDA chief says full disclosure of the information about Ketek could have a chilling effect on the agency's ability to be an independent evaluator of drug safety issues. Ketek has been linked to severe liver problems and several deaths.
2 minute read
May 15, 2007 |

High Court Turns Down Amgen's Appeal in Patent Case

The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen's blockbuster anemia drug Epogen. Amgen urged the justices to rule on the Federal Circuit's practice of considering the factual record behind its patent claims, stating in its filing that the practice "produces incorrect results and causes litigants and district courts to waste tremendous resources."
2 minute read
February 13, 2009 |

Panel finds vaccines with mercury didn't cause autism

Families whose children developed autism after taking a vaccine that contained mercury aren't entitled to compensation from the U.S. government, a panel of court-appointed experts ruled. Three "special masters" appointed by the U.S. Court of Federal Claims in Washington found today that the families failed to show vaccines with thimerosal, a preservative containing mercury, could contribute to autism or gastrointestinal dysfunction.
1 minute read
January 15, 2008 |

Antitrust Trade and Practice

Neal R. Stoll and Shepard Goldfein, partners at Skadden, Arps, Slate, Meagher & Flom, write that early this year, the European Commission is expected to publish its much-anticipated White Paper follow-up to the Green Paper it published in 2005 for antitrust damages actions. The commission may well address the recent Devenish Nutrition decision by the United Kingdom's High Court of Justice, which held that double jeopardy barred certain private antitrust actions for damages.
8 minute read
May 15, 2007 |

High Court Turns Down Amgen's Appeal in Patent Case

The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen's blockbuster anemia drug Epogen. Amgen urged the justices to rule on the Federal Circuit's practice of considering the factual record behind its patent claims, stating in its filing that the practice "produces incorrect results and causes litigants and district courts to waste tremendous resources."
2 minute read
May 15, 2007 |

High court turns down Amgen's appeal in patent case

The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen's blockbuster anemia drug Epogen. Amgen urged the justices to rule on the Federal Circuit's practice of considering the factual record behind its patent claims, stating in its filing that the practice "produces incorrect results and causes litigants and district courts to waste tremendous resources."
2 minute read
June 11, 2007 |

Bristol-Myers pleads guilty on two counts in Plavix antitrust probe, to pay $1 million fine

NEW YORK AP - Drug maker Bristol-Myers Squibb Co. said Monday it pleaded guilty to two counts of making false statements to the Federal Trade Commission regarding the company's botched settlement with Canadian drug maker Apotex Inc. over the blood thinner Plavix.As a result, Bristol-Myers will pay a fine of $1 million, resolving a Justice Department probe.
2 minute read
April 29, 2010 |

Bristol-Myers sees big jumps in Q1 sales, profit

Drugmaker Bristol-Myers Squibb Co. on Thursday reported double-digit jumps in first-quarter sales and net income, beating Wall Street expectations, but it lowered its 2010 profit forecast by a nickel due to the impact of the health care overhaul.
2 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now